1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Anesthetic Effect- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

DelveInsight’s, “ Anesthetic Effect- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries and regions. While the leading brands, companies and chemicals are considered thoroughly, the report also provides details on the drug master filings across the US, Europe and Asia specifically China and India. The research, analysis also presents the global sales forecasts data till 2015. The report is also giving insight about the patent and exclusivity details of all the drugs across the indication.

Data Sources

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
- A snapshot of the global Market therapeutics scenario for Anesthetic Effect.
- A review of the marketed products under prescription for Anesthetic Effect, regulatory information and marketing status.
- Coverage of global patent coverage and detailed commentaries on the US patent challenges.
- Graphical representation of investigational products for patent expiry and market exclusivities across the globe.
- Product profiles for marketed products for Anesthetic Effect with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.
- Coverage of API Manufacturers for Anesthetic Effect drugs in the United States, Europe and Asian Regions with location details.
- Coverage of Regulatory filings in theUS, Europe, and Asia specifically India and China for Anesthetic Effect drugs.
- Coverage of Route of Synthesis of Active Pharmaceutical Ingredient associated with Anesthetic Effect drugs.
- Coverage of Anesthetic Effect Phase III pipeline products featuring sections on product description, mechanism of action, Chemical details and research & development progress.
- Coverage of the United States Drug Master File (US DMF) available for Phase III Pipeline Drugs.
- Key discontinued Marketed products.
- Global Sales Figure from 2011-2015.

Reasons to buy
- Evaluate the marketing status and exclusivity details of Anesthetic Effect key products to exploit opportunities for generic drug development opportunities.
- Identify and understand important and diverse types of therapeutics under Phase III development for Anesthetic Effect.
- Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to ‘Disease’.
- API intelligence over marketed drugs for Anesthetic Effect and gaining primary intelligence over active ingredients manufacturers across the globe.
- API intelligence over leading Phase III pipeline drugs.
- Develop and designstrategies by identifying the API manufacturers for Phase III pipeline products to enhance and expand business potential and scope.
- Understanding the scope of the Phase III Drugs with nil regulatory filings.
- Understanding the chemical route of synthesis of approved drugs for Anesthetic Effect.
- Uncovering opportunities in the rapidly growing the US markets.

Table Of Contents

Anesthetic Effect- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
- Indication Overview
- Marketed Drugs Assessment
- Marketed Details of Drugs by Application Type
- Marketed Details of Drugs (NDA) by Marketing Status
- Marketed Details of Drugs by Patent Expiration Timeline
- The Active Pharmaceutical Ingredient (API) Manufacturers Assessment
- The API Manufacturers by the United States Drug Master File (US DMF) Status
- The API Manufacturers by the US DMF Status (Drug Specific)
- The Active Pharmaceutical Ingredient (API) Manufacturers Assessment for Phase III Pipeline Drugs
- The API Manufacturers by the US DMF Status (Drug Specific)
- Drugs Market Data and Forecasted Sales Figures (2011-2015)
- Marketed Drugs Information
- Drugs Description
- Route of Synthesis
- Global Active Pharmaceutical Manufacturers
- Approval Status
- Patent and Exclusivity Details
- Company Overview
- Phase III Drugs Information
- Phase III Drugs Description
- The United States Drug Master Filings (US DMF)
- Discontinued Drugs Information

List of Tables
Anesthetic Effect Therapeutic Market, US, Marketed Drugs by Application Type, 2014
Anesthetic Effect Therapeutic Market, US, Marketed Drugs by Marketing Status, 2014
Anesthetic Effect Therapeutic Market, US, (Year), 2014
Anesthetic Effect Marketed Drugs, API Manufacturers by US DMF Status, 2014
Anesthetic Effect Marketed Drugs, US DMF Status Drug Specific (Number), 2014
Anesthetic Effect Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2014
Anesthetic Effect Therapeutic Market, Global Sales (in million USD), 2014
Anesthetic Effect Marketed Drugs, API Manufacturers, Global, 2014
Anesthetic Effect Phase III Pipeline Drugs, United States Drug Master File (DMF), 2014
Discontinued Drugs for Anesthetic Effect, 2014

List of Figures
Anesthetic Effect Therapeutic Market, US, Marketed Drugs by Application Type (%), 2014
Anesthetic Effect Therapeutic Market, US, Marketed Drugs by Marketing Status (%), 2014
Anesthetic Effect Therapeutic Market, US, (Year), 2014
Anesthetic Effect Marketed Drugs, API Manufacturers by US DMF Status (%), 2014
Anesthetic Effect Marketed Drugs, US DMF Status Drug Specific (Number), 2014
Anesthetic Effect Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2014
Anesthetic Effect Therapeutic Market, Global Sales (in million USD), 2014
Anesthetic Effect Marketed Drugs, Patent/Exclusivity Expiry (Year), 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Sufentanil Citrate Market: By Applications (Surgery, Epidural Anaesthesia and Medicinal Application) & By Geography (North America, Europe, Asia Pacific & Rest of the World (RoW))-Forecast (2016-2021)

Sufentanil Citrate Market: By Applications (Surgery, Epidural Anaesthesia and Medicinal Application) & By Geography (North America, Europe, Asia Pacific & Rest of the World (RoW))-Forecast (2016-2021)

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Sufentanil, also known as R30730 or brand name Sufenta, is a synthetic opioid analgesic drug which is considerably more potent than its parent drug, fentanyl, morphine. It is used for producing anesthesia ...

Global General Anesthesia Drugs Market - Growth, Trends, and Forecasts (2016 - 2021)

Global General Anesthesia Drugs Market - Growth, Trends, and Forecasts (2016 - 2021)

  • $ 4250
  • Industry report
  • October 2016
  • by Mordor Intelligence LLP

The global general anesthesia drugs market accounted for USD 3,840 million in 2015 and USD 3,983 million in 2016. The market is expected to reach USD 4,760 million by 2021, growing at a CAGR of 3.6% during ...

Global Local Anesthesia Drugs Market - Growth, Trends, and Forecasts (2016 - 2021)

Global Local Anesthesia Drugs Market - Growth, Trends, and Forecasts (2016 - 2021)

  • $ 4250
  • Industry report
  • October 2016
  • by Mordor Intelligence LLP

The global local anesthesia drugs market accounted for USD 8,160 million in 2015 and USD 8,335 million in 2016. The market is expected to reach USD 9,240 million by 2021, growing at a CAGR of 2.1% during ...


Download Unlimited Documents from Trusted Public Sources

Opioid and Anesthetics Market in Australia

  • December 2016
    5 pages
  • Opioid  

    Anesthetics  

    Analgesic  

  • Australia  

View report >

Opioid Market in the US

  • November 2016
    4 pages
  • Opioid  

  • United States  

View report >

Hormone Market in the US

  • November 2016
    20 pages
  • Hormone  

  • United States  

View report >

Related Market Segments :

Anesthetics

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.